MyJournals Home  

RSS FeedsDacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase (British Journal of Cancer)

 
 

18 june 2019 09:01:08

 
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase (British Journal of Cancer)
 




 
74 viewsCategory: Oncology
 
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia (British Journal of Cancer)
Fibroblasts shape PDAC architecture (Nature Reviews Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten